JP6053818B2 - 白血球の細胞内標的及び細胞外標的の標識方法 - Google Patents
白血球の細胞内標的及び細胞外標的の標識方法 Download PDFInfo
- Publication number
- JP6053818B2 JP6053818B2 JP2014548248A JP2014548248A JP6053818B2 JP 6053818 B2 JP6053818 B2 JP 6053818B2 JP 2014548248 A JP2014548248 A JP 2014548248A JP 2014548248 A JP2014548248 A JP 2014548248A JP 6053818 B2 JP6053818 B2 JP 6053818B2
- Authority
- JP
- Japan
- Prior art keywords
- solution
- leukocytes
- combination
- vitro method
- intracellular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 88
- 210000000265 leukocyte Anatomy 0.000 title claims description 47
- 230000003834 intracellular effect Effects 0.000 title claims description 33
- 238000002372 labelling Methods 0.000 title claims description 9
- 239000000243 solution Substances 0.000 claims description 106
- 210000004027 cell Anatomy 0.000 claims description 38
- 239000003795 chemical substances by application Substances 0.000 claims description 30
- 239000011230 binding agent Substances 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 23
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 18
- 210000004369 blood Anatomy 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 15
- 239000004094 surface-active agent Substances 0.000 claims description 15
- 210000003743 erythrocyte Anatomy 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 12
- 238000005119 centrifugation Methods 0.000 claims description 11
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 10
- 238000004132 cross linking Methods 0.000 claims description 10
- 238000000684 flow cytometry Methods 0.000 claims description 9
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 9
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 8
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 8
- 230000003472 neutralizing effect Effects 0.000 claims description 8
- 229920002866 paraformaldehyde Polymers 0.000 claims description 8
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 6
- 235000019270 ammonium chloride Nutrition 0.000 claims description 5
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 102000004895 Lipoproteins Human genes 0.000 claims description 4
- 108090001030 Lipoproteins Proteins 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 206010003445 Ascites Diseases 0.000 claims description 3
- 210000001185 bone marrow Anatomy 0.000 claims description 3
- 230000002934 lysing effect Effects 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims 10
- 230000001413 cellular effect Effects 0.000 claims 1
- 238000005406 washing Methods 0.000 description 29
- 238000010186 staining Methods 0.000 description 18
- 239000000834 fixative Substances 0.000 description 5
- 239000000872 buffer Substances 0.000 description 4
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000010212 intracellular staining Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 150000001335 aliphatic alkanes Chemical group 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 230000008823 permeabilization Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- -1 (hydroxymethyl) amino Chemical group 0.000 description 1
- UEFCKYIRXORTFI-UHFFFAOYSA-N 1,2-thiazolidin-3-one Chemical compound O=C1CCSN1 UEFCKYIRXORTFI-UHFFFAOYSA-N 0.000 description 1
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70514—CD4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70589—CD45
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Physiology (AREA)
- Ecology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11290586.4A EP2607899B1 (en) | 2011-12-21 | 2011-12-21 | Method for labeling intracellular and extracellular targets of leukocytes |
| EP11290586.4 | 2011-12-21 | ||
| PCT/IB2012/003071 WO2013093642A1 (en) | 2011-12-21 | 2012-12-21 | Method for labeling intracellular and extracellular targets of leukocytes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015500999A JP2015500999A (ja) | 2015-01-08 |
| JP6053818B2 true JP6053818B2 (ja) | 2016-12-27 |
Family
ID=47563336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014548248A Active JP6053818B2 (ja) | 2011-12-21 | 2012-12-21 | 白血球の細胞内標的及び細胞外標的の標識方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9678073B2 (pt) |
| EP (2) | EP3104177B1 (pt) |
| JP (1) | JP6053818B2 (pt) |
| KR (1) | KR102067742B1 (pt) |
| CN (1) | CN104011542B (pt) |
| AU (2) | AU2012356324A1 (pt) |
| BR (1) | BR112014015204B1 (pt) |
| CA (1) | CA2859605C (pt) |
| MX (1) | MX352837B (pt) |
| WO (1) | WO2013093642A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3104177B1 (en) | 2011-12-21 | 2020-11-25 | Beckman Coulter, Inc. | Method for labeling intracellular and extracellular targets of leukocytes |
| CA2936167A1 (en) | 2015-07-15 | 2017-01-15 | Streck, Inc. | Method and device for stabilizing of proteins |
| JPWO2017141789A1 (ja) * | 2016-02-19 | 2018-12-13 | コニカミノルタ株式会社 | 血液由来検体の保管方法および希少細胞の判定方法 |
| CN111699388B (zh) * | 2017-12-12 | 2024-08-02 | 10X基因组学有限公司 | 用于单细胞处理的系统和方法 |
| EP3821245A1 (en) * | 2018-07-12 | 2021-05-19 | Beckman Coulter, Inc. | Fixable viability dyes and their uses |
| CN111807809B (zh) * | 2019-04-10 | 2021-12-28 | 盐城工业职业技术学院 | 一种棕榈纳米纤维-石墨烯-碳纳米管复合气凝胶的制备方法 |
| CN113884671A (zh) * | 2021-09-27 | 2022-01-04 | 苏州东岭生物技术有限公司 | 一种流式染色试剂盒及其配置方法和应用方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6179163A (ja) * | 1984-09-26 | 1986-04-22 | Toa Medical Electronics Co Ltd | 血球測定用試薬 |
| JP2891302B2 (ja) * | 1990-03-01 | 1999-05-17 | シスメックス株式会社 | 血液中の白血球およびヘモグロビンの測定用試薬 |
| EP0513394B1 (en) * | 1990-12-08 | 1995-09-27 | Mory Suntour Inc. | Change gear mechanism for bicycle |
| US5422277A (en) * | 1992-03-27 | 1995-06-06 | Ortho Diagnostic Systems Inc. | Cell fixative composition and method of staining cells without destroying the cell surface |
| ES2284160T3 (es) * | 1993-02-25 | 2007-11-01 | Abbott Laboratories | Sistema reactivo multiuso capaz de lisar rapidamente muestras de sangre completa. |
| US5891734A (en) * | 1994-08-01 | 1999-04-06 | Abbott Laboratories | Method for performing automated analysis |
| JP3170176B2 (ja) * | 1995-05-17 | 2001-05-28 | 大塚製薬株式会社 | 薬剤耐性獲得癌細胞の検出方法 |
| JP2000509146A (ja) * | 1996-04-12 | 2000-07-18 | オンコール，インコーポレーテッド | 遅延クエンチングによりホルムアルデヒド固定を制御する方法および組成物 |
| ES2212615T3 (es) * | 1998-08-27 | 2004-07-16 | Mayo Foundation For Medical Education And Research | Metodos y materiales para el diagnostico de una angina inestable. |
| US6210969B1 (en) * | 1999-04-28 | 2001-04-03 | Coulter International Corp. | Composition and method for differentiation of basophil and eosinophil subpopulations of leukocytes in blood |
| US7354773B2 (en) * | 2003-05-14 | 2008-04-08 | Beckman Coulter, Inc. | Method and apparatus for preparing cell samples for intracellular antigen detection using flow cytometry |
| JP2005274425A (ja) * | 2004-03-25 | 2005-10-06 | New Industry Research Organization | Ｐｘプローブを用いたフォスファチジルイノシトール３リン酸の検出方法 |
| US20050266503A1 (en) * | 2004-05-24 | 2005-12-01 | Esoterix, Inc. | Simultaneous assay of target and target-drug binding |
| US7803523B2 (en) * | 2004-08-27 | 2010-09-28 | University Health Network | Whole blood preparation for cytometric analysis of cell signaling pathways |
| US7678578B2 (en) * | 2005-02-07 | 2010-03-16 | Beckman Coulter, Inc. | Cell permeabilization and stabilization reagent and method of use |
| JP5252682B2 (ja) * | 2005-02-25 | 2013-07-31 | 学校法人日本大学 | 哺乳動物ｔ細胞のサイトカインの分析方法と関連する一切の疾患の評価法と予防・治療の分析 |
| US7235404B2 (en) * | 2005-05-04 | 2007-06-26 | Beckman Coulter, Inc. | Cyanide-free lytic reagent composition and method of use for hemoglobin and white blood cell measurement |
| TWI333959B (en) * | 2005-08-31 | 2010-12-01 | Academia Sinica | Methods and reagents for the analysis and purification of polysaccharides |
| US7625757B2 (en) * | 2006-01-27 | 2009-12-01 | Sysmex Corporation | Reagent for immature leukocyte analysis and reagent kit |
| JP4976038B2 (ja) * | 2006-03-29 | 2012-07-18 | シスメックス株式会社 | 血液学的試料の測定方法 |
| HU0600578D0 (en) * | 2006-07-13 | 2006-09-28 | Szilak Labor Bioinformatikai E | Nuclear protein transport |
| JP5214603B2 (ja) * | 2007-06-25 | 2013-06-19 | シスメックス株式会社 | 幼若白血球の分析用試薬及び分析用試薬キット |
| ES2684695T3 (es) * | 2007-06-25 | 2018-10-04 | Sysmex Corporation | Reactivo y kit de reactivos para el análisis de leucocitos primitivos |
| US20090155838A1 (en) * | 2007-11-28 | 2009-06-18 | Smart Tube, Inc. | Devices, systems and methods for the collection, stimulation, stabilization, and analysis of a biological sample |
| EP3104177B1 (en) | 2011-12-21 | 2020-11-25 | Beckman Coulter, Inc. | Method for labeling intracellular and extracellular targets of leukocytes |
-
2011
- 2011-12-21 EP EP16001447.8A patent/EP3104177B1/en active Active
- 2011-12-21 EP EP11290586.4A patent/EP2607899B1/en active Active
-
2012
- 2012-12-21 CN CN201280063544.1A patent/CN104011542B/zh active Active
- 2012-12-21 CA CA2859605A patent/CA2859605C/en active Active
- 2012-12-21 JP JP2014548248A patent/JP6053818B2/ja active Active
- 2012-12-21 KR KR1020147016948A patent/KR102067742B1/ko active IP Right Grant
- 2012-12-21 BR BR112014015204-7A patent/BR112014015204B1/pt active IP Right Grant
- 2012-12-21 MX MX2014007284A patent/MX352837B/es active IP Right Grant
- 2012-12-21 US US14/366,024 patent/US9678073B2/en active Active
- 2012-12-21 AU AU2012356324A patent/AU2012356324A1/en not_active Abandoned
- 2012-12-21 WO PCT/IB2012/003071 patent/WO2013093642A1/en active Application Filing
-
2016
- 2016-06-21 US US15/188,856 patent/US11635433B2/en active Active
-
2018
- 2018-10-11 AU AU2018247279A patent/AU2018247279B2/en active Active
-
2023
- 2023-03-21 US US18/124,224 patent/US20230288416A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140100536A (ko) | 2014-08-14 |
| AU2018247279B2 (en) | 2020-12-24 |
| CA2859605A1 (en) | 2013-06-27 |
| AU2018247279A1 (en) | 2018-11-01 |
| US20230288416A1 (en) | 2023-09-14 |
| CN104011542A (zh) | 2014-08-27 |
| EP3104177A1 (en) | 2016-12-14 |
| BR112014015204A2 (pt) | 2017-06-13 |
| BR112014015204A8 (pt) | 2017-06-13 |
| CN104011542B (zh) | 2016-04-27 |
| BR112014015204B1 (pt) | 2021-03-30 |
| MX2014007284A (es) | 2015-10-29 |
| KR102067742B1 (ko) | 2020-01-20 |
| MX352837B (es) | 2017-12-11 |
| WO2013093642A1 (en) | 2013-06-27 |
| JP2015500999A (ja) | 2015-01-08 |
| EP2607899A1 (en) | 2013-06-26 |
| US9678073B2 (en) | 2017-06-13 |
| US11635433B2 (en) | 2023-04-25 |
| AU2012356324A1 (en) | 2014-07-03 |
| CA2859605C (en) | 2020-07-07 |
| EP3104177B1 (en) | 2020-11-25 |
| US20150010923A1 (en) | 2015-01-08 |
| US20160299139A1 (en) | 2016-10-13 |
| EP2607899B1 (en) | 2016-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6053818B2 (ja) | 白血球の細胞内標的及び細胞外標的の標識方法 | |
| US20210130866A1 (en) | Cellular Analysis of Body Fluids | |
| ES2930651T3 (es) | Métodos y composiciones para la detección citométrica de células tumorales circulantes en una muestra | |
| JP2005501236A (ja) | 分析用の細胞および生物学的検体の安定化 | |
| ES2846224T3 (es) | Enriquecimiento de células tumorales circulantes agotando glóbulos blancos | |
| TW201439515A (zh) | 用於高嚴苛度細胞處理及抗原修復之組成物 | |
| JP2020030180A (ja) | 血液試料の溶血剤 | |
| CN112504793B (zh) | 用于渗透和固定血细胞的试剂及分析方法 | |
| JP2017058326A (ja) | 腫瘍細胞の検出方法 | |
| Wang et al. | Variables in the quantification of CD4 in normals and hairy cell leukemia patients | |
| US11047850B2 (en) | Composition for stabilization of antibody formulations containing PerCP |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140624 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20151216 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20161026 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20161125 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20161129 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6053818 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |